Skip to content

Prkag2 Related Cardiomyopathy Cn375941

Published: July 22, 2026Updated: August 20, 2026

A heart muscle disease linked to PRKAG2 gene changes. It may cause the heart walls to thicken and lead to irregular heartbeats. Regular cardiac monitoring and symptom management are important.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Palpitations

!

Syncope

!

Ventricular arrhythmias

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Dyspnea

(cardiovascular)

Dizziness

(cardiovascular)

Peripheral edema

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Beta-blockers

Beta-blockers are used as first-line therapy to reduce heart rate, decrease myocardial oxygen demand, and prevent arrhythmias in PRKAG2-related cardiomyopathy. They help manage symptoms of chest pain and palpitations associated with this condition.

medication
2

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Implantable Cardioverter-Defibrillator (ICD)

ICD placement is recommended for patients with PRKAG2 cardiomyopathy who have had ventricular arrhythmias or have significant cardiac dysfunction. The device continuously monitors heart rhythm and delivers shocks if life-threatening arrhythmias occur.

surgical

Additional treatment options

Activity restriction and exercise modification

Patients should avoid competitive sports and high-intensity exercise that may trigger arrhythmias. A tailored exercise program focusing on moderate, low-intensity activities can help maintain cardiovascular fitness without overexerting the heart.

lifestyle

Antiarrhythmic medications

Antiarrhythmic drugs may be prescribed to control supraventricular arrhythmias commonly seen in PRKAG2 cardiomyopathy. These medications help maintain normal sinus rhythm and reduce symptom burden.

medication

Regular cardiac surveillance

Comprehensive cardiac monitoring including annual echocardiograms, Holter monitoring, and periodic exercise stress testing helps track disease progression and guide treatment adjustments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Prkag2 Related Cardiomyopathy Cn375941?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Murdock G, Chen W, Liu Y. PRKAG2 cardiomyopathy: From genetics to clinical manifestations. Cardiovasc Res Rev. 2022.

review2022
2

International Society for Genetic Heart Diseases. Guidelines for diagnosis and management of metabolic cardiomyopathies. Heart Rhythm J. 2023.

guideline2023
3

Tanaka H, Gomez-Martin J, Fernandez-Portal R. Clinical outcomes in PRKAG2 mutation carriers: A prospective cohort study. JACC Heart Fail. 2021.

clinical_trial2021
4

Kimura S, Nakashima K, Wang L. Molecular mechanisms of AMPK dysregulation in cardiac glycogen storage disease. Cell Mol Cardiol. 2020.

other2020

Medication Comparisons

Compare medications used to treat Prkag2 Related Cardiomyopathy Cn375941. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy